RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEWD8AD193DE2E6928F
https://w3id.org/ripe/ripe-kg/work/RIPEWD8AD193DE2E6928F
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.jad.2017.12.049The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
dcterms:title |
Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
rdf:type |
node1 |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
rdf:type |
owl:Thing |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
rdf:type |
prov:Entity |
ripekg:work/RIPEWD8AD193DE2E6928FPolycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications |
rdf:type |
ripe:WorkWork |